send to a friend by email
2014-04-29
According to
Jerusalem Pharmaceuticals Company
JPH data for the first three months of the year, net loss reached (267,179)
USD, compared with a net profit after taxes of 719,391
USD from the first three months of
2013. Total assets of the company reached 54,137,814
USD as of March 31st,
2014, compared to total assets of 53,934,080
USD as of December 31st,
2013, a net
increase of 0.4%. Total liabilities of the company reached 16,889,583
USD as of March 31st,
2014, compared to total liabilities of 16,250,816
USD as of December 31st,
2013, a net
increase of 3.9%. Net ownership equity of the company reached 37,248,231
USD (including 613,415
USD in Non-controlling interest) as of March 31st,
2014, compared with a net ownership equity of 37,683,265
USD (including 705,854
USD in Non-controlling interest) as of December 31st,
2013, a net
decrease of 1.2% in the first three months.
|
|